SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-18-035071
Filing Date
2018-05-22
Accepted
2018-05-22 16:12:12
Documents
46
Period of Report
2018-02-28

Document Format Files

Seq Description Document Type Size
1 10-K a17-27960_110k.htm 10-K 933804
2 EX-31.1 a17-27960_1ex31d1.htm EX-31.1 10190
3 EX-31.2 a17-27960_1ex31d2.htm EX-31.2 10606
4 EX-32.1 a17-27960_1ex32d1.htm EX-32.1 6175
5 EX-32.2 a17-27960_1ex32d2.htm EX-32.2 6170
  Complete submission text file 0001104659-18-035071.txt   2942145

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20180228.xml EX-101.INS 393109
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20180228.xsd EX-101.SCH 34991
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20180228_cal.xml EX-101.CAL 24152
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20180228_lab.xml EX-101.LAB 271648
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20180228_pre.xml EX-101.PRE 186230
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20180228_def.xml EX-101.DEF 93632
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 18852571
SIC: 2835 In Vitro & In Vivo Diagnostic Substances